N04.29
Other nephrotic syndrome with diffuse membranous glomerulonephritis
Clinical Classification Guidelines
Medical Intelligence & Overview
Other nephrotic syndrome with diffuse membranous glomerulonephritis is a kidney disorder characterized by widespread damage to the glomeruli, which are the tiny filters in your kidneys. This condition leads to excessive protein loss in the urine, swelling, and other related symptoms. It is a specific form of nephrotic syndrome, classified under ICD-10 code N04.29, indicating a type of glomerular disease with distinct features involving the membranous pattern of kidney tissue injury.
Causes & Symptoms
Clinical Causes: Immune system abnormalities causing antibody deposits in the glomeruli Infections such as hepatitis B, hepatitis C, and syphilis Certain medications, including nonsteroidal anti-inflammatory drugs (NSAIDs) and gold compounds Underlying autoimmune conditions such as lupus erythematosus Malignancies or cancers that can trigger immune responses affecting the kidneys Idiopathic cases where no specific cause can be identified
Key Symptoms: Swelling or edema, especially in the ankles, legs, and around the eyes Foamy or frothy urine due to high protein levels Weight gain caused by fluid retention Fatigue and weakness Loss of appetite Loss of urine protein and sometimes blood in the urine
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of clinical evaluation and laboratory tests. Key diagnostic measures include: - Urinalysis to detect protein, blood, and other abnormalities - Blood tests to measure kidney function, levels of protein, and presence of antibodies - Kidney biopsy to examine tissue samples under a microscope, revealing the characteristic thickening of the glomerular basement membrane associated with membranous glomerulonephritis - Imaging tests such as ultrasound may be used to assess kidney size and structure These tests help confirm the presence of this specific type of nephrotic syndrome and determine its severity and cause.
Treatment Protocols: Management of this condition aims to reduce protein loss, control symptoms, and address any underlying causes. Treatments often include: - Medications such as corticosteroids to suppress immune activity - Immunosuppressive drugs in cases linked to autoimmune conditions - Angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) to lower blood pressure and reduce proteinuria - Diuretics to manage edema and fluid retention - Dietary adjustments, including reduced salt intake - Regular monitoring of kidney function and repeat testing to evaluate treatment response In some cases, specific therapies targeting underlying infections or conditions may be necessary. Ongoing management and close medical supervision are crucial to prevent progression to chronic kidney disease or kidney failure.
Clinical Advice & FAQs
Billing Guidance
Is N04.29 a billable ICD-10 code?
Yes, N04.29 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report N04.29?
Clinical documentation must specify the nature of Other nephrotic syndrome with diffuse membranous glomerulonephritis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference